NEXPOINT ASSET MANAGEMENT, L.P. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 201 filers reported holding HERON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.

Quarter-by-quarter ownership
NEXPOINT ASSET MANAGEMENT, L.P. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$514,105
-11.2%
499,1310.0%0.07%
-16.7%
Q2 2023$578,992
-23.2%
499,1310.0%0.08%
+2.4%
Q1 2023$753,688
-39.6%
499,1310.0%0.08%
-15.5%
Q4 2022$1,247,828
-40.7%
499,1310.0%0.10%
-31.2%
Q3 2022$2,106,000
+51.2%
499,1310.0%0.14%
+13.7%
Q2 2022$1,393,000
-51.2%
499,1310.0%0.12%
-66.3%
Q1 2022$2,855,000
-37.3%
499,1310.0%0.37%
-42.7%
Q4 2021$4,557,000
-14.6%
499,1310.0%0.64%
-30.1%
Q3 2021$5,336,000
-31.1%
499,1310.0%0.92%
-45.7%
Q2 2021$7,747,000
-21.6%
499,131
-18.1%
1.69%
-34.5%
Q1 2021$9,880,000
-35.3%
609,531
-15.5%
2.58%
-48.6%
Q4 2020$15,261,000
+42.8%
721,0640.0%5.02%
+107.6%
Q3 2020$10,686,000
+0.7%
721,0640.0%2.42%
+1.2%
Q2 2020$10,607,000
+16.2%
721,064
-7.3%
2.39%
+38.6%
Q1 2020$9,129,000
-67.6%
777,599
-35.1%
1.72%
-19.3%
Q4 2019$28,144,000
-2.6%
1,197,599
-23.3%
2.14%
+18.5%
Q3 2019$28,896,0001,561,9811.80%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders